Harold J, Bellone S, Manavell DD, Mutlu L, et al. Corrigendum to "Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma". Gynecol Oncol 2023;170:334.
PMID: 36906375